88IV - Public company info - JW (Cayman) Therapeutics Co. Ltd

Input the stock code or the company name

JW (Cayman) Therapeutics Co. Ltd, 02126.HK - Cash Flow	2019-12	2018-12
Net Cash Flow from Operating Activities	-190,743	-107,318
Net Cash Flow from Return on Investments & Servicing of Finance	157	-1,825
Interest Received	1,820	1,092
Interest Paid	-1,663	-2,917
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-117,554	-44,148
Additions to Fixed Assets	-101,946	-43,647
Disposal of Fixed Assets	0	0
Increase in Investments	0	0
Decrease in Investments	0	0
Net Cash Flow with Related Parties	0	0
Others	-15,608	-501
Net Cash Flow before Financing Activities	-308,140	-153,291
Net Cash Flow from Financing Activities	415,712	252,742
New Loans	50,823	10,054
Loans Repayment	-45,297	-2,643
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	373,811	281,706
Net Cash Flow with Related Parties	0	0
Others	36,375	-36,375
Increase(Decrease) in Cash & Cash Equivalents	107,572	99,451
Cash & Cash Equivalents at Beginning of Year	133,663	21,202
Net Cash Flow due to Change in Exchange Rate/Others	13,631	13,010
Cash & Cash Equivalents at End of Year	254,866	133,663
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - JW (Cayman) Therapeutics Co. Ltd , 02126.HK